Home/Filings/4/0001562180-22-003846
4//SEC Filing

Gregory Philip D 4

Accession 0001562180-22-003846

CIK 0001860782other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 8:36 PM ET

Size

7.1 KB

Accession

0001562180-22-003846

Insider Transaction Report

Form 4
Period: 2022-03-01
Gregory Philip D
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2022-03-01+95,00095,000 total
    Exercise: $13.41Exp: 2032-03-01Common Stock (95,000 underlying)
  • Award

    Common Stock

    2022-03-01+47,500109,160 total
Footnotes (2)
  • [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/01/2023, 25% on 01/01/2024, 25% on 01/01/2025, and 25% on 01/01/2026.
  • [F2]This stock option vests over a four-year period at the rate of 25% on 01/01/2023 and then in 36 equal monthly installments thereafter.

Issuer

2seventy bio, Inc.

CIK 0001860782

Entity typeother

Related Parties

1
  • filerCIK 0001343543

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 8:36 PM ET
Size
7.1 KB